|
|
||||||
|
|
||||||
|
|
||||||
|
|
 |
|
Key investors include: Clarus Ventures Novo Ventures Prospect Venture Partners Sanderling Ventures Vivo VenturesNeoMend is the sole owner of its entire technology and product portfolio, and is seeking strategic partners for key therapy opportunities |
|
|
|
|
||